Akso Health Group
AHGNASDAQFinancial Services● Active
$1.44
+$0.11(+7.92%)
Market Cap$135965214
P/E Ratio—
52W High$2.5
52W Low$1.07
Akso Health Group (AHG) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AHG · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2025Report Date: Mar 28, 2025EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q1 FY2025
FY ends December
Report Date
Mar 28, 2025
After Market Close
AHG reports quarterly as a NASDAQ-listed Financial - Credit Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 16, 2026 | -$0.18 | — | — | — | $0.01B | — |
| ◌ Q1 FY2026 | Feb 10, 2026 | — | — | — | — | — | — |
| ◌ Q4 FY2025 | Nov 13, 2025 | — | — | — | — | — | — |
| — Q1 FY2025 | Mar 28, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2024 | Jul 12, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2024 | Apr 30, 2024 | — | -$0.14 | — | $0.00B | — | — |
| — Q1 FY2024 | Jan 12, 2024 | — | -$0.07 | — | $0.00B | — | — |
| — Q1 FY2024 | Jan 1, 2024 | — | -$0.04 | — | $0.00B | $0.01B | -89.4% |
Q2 FY2026
Jun 16, 2026
EPS Actual
—
EPS Est.
-$0.18
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 10, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 13, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 28, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Jul 12, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Apr 30, 2024
EPS Actual
-$0.14
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Jan 12, 2024
EPS Actual
-$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Jan 1, 2024
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2025 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q1 FY2025 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q4 FY2024 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Q3 FY2024 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Q2 FY2024 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Q4 FY2019 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2019 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2025 | Mar 28, 2025 | — | $1.26 | $1.18 | -6.35% |
| — Q3 FY2024 | Jul 12, 2024 | — | $1.12 | $1.10 | -1.79% |
| — Q2 FY2024 | Apr 30, 2024 | — | $0.78 | $0.75 | -4.18% |
| — Q1 FY2024 | Jan 12, 2024 | — | $0.89 | $1.07 | +20.22% |
| — Q1 FY2024 | Jan 1, 2024 | — | $0.74 | $1.13 | +52.70% |
| — Q3 FY2023 | Jul 14, 2023 | — | $0.33 | $0.33 | +1.23% |
| — Q3 FY2023 | Jul 14, 2023 | — | $0.33 | $0.33 | +1.23% |
| — Q1 FY2023 | Feb 16, 2023 | — | $0.42 | $0.43 | +2.41% |
Q1 FY2025-6.35%
Report Date
Mar 28, 2025
EPS Beat/Miss
—
Price Before
$1.26
Price After
$1.18
Q3 FY2024-1.79%
Report Date
Jul 12, 2024
EPS Beat/Miss
—
Price Before
$1.12
Price After
$1.10
Q2 FY2024-4.18%
Report Date
Apr 30, 2024
EPS Beat/Miss
—
Price Before
$0.78
Price After
$0.75
Q1 FY2024+20.22%
Report Date
Jan 12, 2024
EPS Beat/Miss
—
Price Before
$0.89
Price After
$1.07
Q1 FY2024+52.70%
Report Date
Jan 1, 2024
EPS Beat/Miss
—
Price Before
$0.74
Price After
$1.13
Q3 FY2023+1.23%
Report Date
Jul 14, 2023
EPS Beat/Miss
—
Price Before
$0.33
Price After
$0.33
Q3 FY2023+1.23%
Report Date
Jul 14, 2023
EPS Beat/Miss
—
Price Before
$0.33
Price After
$0.33
Q1 FY2023+2.41%
Report Date
Feb 16, 2023
EPS Beat/Miss
—
Price Before
$0.42
Price After
$0.43
Beat Rate0 / 8 quarters
Largest Move+52.70% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AHG ends December
Akso Health Group (AHG) most recently reported earnings on March 28, 2025 for Q1 FY2025, posting EPS of $-0.00 (in line with the analyst consensus of —).
Each quarter, investors track AHG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AHG revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AHG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AHG earnings · 4 questionsAkso Health Group's next earnings report is expected around TBD. AHG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AHG historically reports after market close (AMC).
AHG earnings datewhen is AHG earningsAHG next earnings datewhen does AHG report earningsAHG earnings calendar
▸ Source: FMP · Akso Health Group SEC filings · US GAAP · Akso Health Group SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026